Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Apr 3;5(2):29.
doi: 10.3390/jof5020029.

A Bright Future for Fluorescence Imaging of Fungi in Living Hosts

Ambre F Chapuis  1 , Elizabeth R Ballou  2 , Donna M MacCallum  3
Affiliations
Review

A Bright Future for Fluorescence Imaging of Fungi in Living Hosts

Ambre F Chapuis et al. J Fungi (Basel). .

Abstract

Traditional in vivo investigation of fungal infection and new antifungal therapies in mouse models is usually carried out using post mortem methodologies. However, biomedical imaging techniques focusing on non-invasive techniques using bioluminescent and fluorescent proteins have become valuable tools. These new techniques address ethical concerns as they allow reduction in the number of animals required to evaluate new antifungal therapies. They also allow better understanding of the growth and spread of the pathogen during infection. In this review, we concentrate on imaging technologies using different fungal reporter proteins. We discuss the advantages and limitations of these different reporters and compare the efficacy of bioluminescent and fluorescent proteins for fungal research.

Keywords: 3Rs; bioluminescence; fluorescent reporters; iRFP; infection models; live imaging.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

Cited by

References

    1. Brown G.D., Denning D.W., Gow N.A.R., Levitz S.M., Netea M.G., White T.C. Hidden killers: Human fungal infections. Sci. Transl. Med. 2012;4:13. doi: 10.1126/scitranslmed.3004404. - DOI - PubMed
    1. Rajasingham R., Smith R.M., Park B.J., Jarvis J.N., Govender N.P., Chiller T.M., Denning D.W., Loyse A., Boulware D.R. Global burden of disease of HIV-associated cryptococcal meningitis: An updated analysis. Lancet Infect. Dis. 2017;17:873–881. doi: 10.1016/S1473-3099(17)30243-8. - DOI - PMC - PubMed
    1. Fukuda Y., Homma T., Suzuki S., Takuma T., Tanaka A., Yokoe T., Ohnishi T., Niki Y., Sagara H. High burden of Aspergillus fumigatus infection among chronic respiratory diseases. Chron. Respir. Dis. 2018:1–7. doi: 10.1177/1479972318761654. - DOI - PMC - PubMed
    1. Barchiesi F., Spreghini E., Baldassarri I., Marigliano A., Arzeni D., Giannini D., Scalise G. Sequential therapy with caspofungin and fluconazole for Candida albicans infection. Antimicrob. Agents Chemother. 2004;48:4056–4058. doi: 10.1128/AAC.48.10.4056-4058.2004. - DOI - PMC - PubMed
    1. Sanglard D. Emerging threats in antifungal-resistant fungal pathogens. Front. Med. 2016;3:1–10. doi: 10.3389/fmed.2016.00011. - DOI - PMC - PubMed

LinkOut - more resources